| Julian Amey Principal Fellow International Manufacturing Centre, University of Warwick | |
| Siavash Alamouti Director Vodafone Group Research & Development | |
| Jorge Gallardo Ballart Chairman Almirall S.A | |
| Mark Becker Career Healthcare Analyst Fidelity Worldwide Investments | |
| Professor Sir John Bell Regius Professor of Medicine, Government Advisor on UK Life Sciences Strategy Oxford University | |
| Serge Bernasconi Chief Executive Officer MedTech Europe Eucomed, EDMA | |
| Darren Campili Head of EMEA, Healthcare Deutsche Bank | |
| Frances Cloud Managing Director Pharmacloud | |
| Lord Sebastian Coe Chair LOCOG | |
| Neil de Crescenzo Senior Vice President and General Manager Oracle Health Sciences | |
| Giles Denham Head of Medicines Pharmacy and Industry Group, Department of Health | |
| John Dineen President & CEO GE Healthcare | |
| Joaquin Duato Worldwide Chairman, Pharmaceuticals Johnson & Johnson | |
| Peter Greenleaf President MedImmune | |
| Jane Griffiths Group Company Chairman Janssen Europe, Middle East and Africa | |
| David-Alexandre Gros Chief Strategy Officer Sanofi | |
| Simon Hammett EMEA Head of Healthcare & Life Sciences Deloitte LLP | |
| Pete Harpum Grenoble Ecole de Management, Affiliate Professor Biotechnology Management, Visiting Lecturer University of Manchester | |
| Niklas Hedberg Head, Department of Pharmaceutical Submissions Dental and Pharmaceutical Benefits Agency (TLV), Sweden | |
| Franz Humer Chairman of the Board Roche | |
| Andrew Jack Pharmaceutical Correspondent Financial Times | |
| Ken Jones President and CEO Astellas Pharma Europe | |
| Panos Kanavos Reader in International Health Policy, Deputy Director LSE Health | |
| Ismail Kola President, New Medicines UCB | |
| Duncan Learmouth Senior Vice President, Developing Countries and Market Access GlaxoSmithKline | |
| Israel Makov Chairman SUN Pharmaceutical Industries Limited | |
| Gideon Mantel CEO Treato | |
| Reynold W. (Pete) Mooney Global Leader, Life Sciences and Health Care Deloitte Touche Tohmatsu Limited | |
| Frank Morich Director and Chief Commercial Officer Takeda Pharmaceutical Company Limited | |
| David Morris Global Head Development Franchise, Primary Care Novartis | |
| Trevor Mundel President, Global Health Program Bill & Linda Gates Foundation | |
| Professor Sir Michael Rawlins Chair National Institute for Health & Clinical Excellence | |
| David Reddy CEO Medicines for Malaria Venture | |
| Cavan Redmond CEO WebMD Health Corp | |
| Julian Remnant R&D Practice Lead (Europe) Deloitte | |
| Greg Rossi Vice President, Payer and Real World Evidence AstraZeneca | |
| Nancy Santanello Vice President and Head of Epidemiology Merck Research Laboratories | |
| Corinne Savill Global Head of Pricing and Market Access Novartis | |
| Ulrich Schriek Senior Vice President, Corporate Business Development QIAGEN | |
| Moncef Slaoui Chairman, Research & Development GlaxoSmithKline | |
| Martin Velasco Chairman AC Immune | |
| Ulf Wiinberg CEO Lundbeck | |
| Marcus Wilson President HealthCore, a subsidiary of WellPoint | |
| Steve Yang Vice President, Head of R&D for Asia and Emerging Markets AstraZeneca | |
